• Review of neutropenia management in older cancer patients, prepared August 2008. [FR, collaborating writer]

• Detailed abstracts of published journal articles about anti-angiogenic therapy in breast, colorectal, ovarian, and renal cancer, prepared June 2008 to September 2008. [FR, writer]

• CME newsletter on treatment of indolent non-Hodgkin’s lymphoma, prepared June 2008. [FR, writer]

• Educational materials for sales representatives about targeted therapy for non–small-cell lung cancer and pancreatic cancer, prepared June 2008. [FR, writer]

• Quantitative literature analysis about an anti-anemia drug, prepared May 2008. [BC, researcher]

• Three posters for ASCO about anti-angiogenic treatment of breast and ovarian cancer, prepared April 2008. [FR, collaborating writer]

• Review about the use of hematopoietic growth factors to aid recovery from acute radiation syndrome, prepared March 2008. [FR, collaborating writer]

• Slide libraries summarizing all major clinical trials on the use of bisphosphonates to treat skeletal-related events in breast, lung, prostate, and renal cancer and multiple myeloma, prepared December 2007 to July 2008. [BAC and FR, writers]

• Caley, BA. The new sarcoma story: strategies for diagnosing and treating sarcomas shift to a more patient-specific approach. CURE: Cancer Updates, Research and Education. 2007;6(5):42-49.

• Hematologic Diseases and Disorders (teaching slides for geriatrics residents). American Geriatrics Society, www.frycomm.com/ags/teachingslides, July 2007. [BAC and FR, writers]

• Qualitative literature review on VATS lobectomy, prepared May 2007. [FR, researcher]

• Educational website content for cancer patients, prepared January to June 2007. [BAC, writer]
      Colorectal Cancer
      Non–small-cell Lung Cancer
      Small-cell Lung Cancer
      New Discoveries in Cancer (biologic and targeted therapies, gene therapy, therapeutic vaccines, and individualized treatment)

• Recent developments in the treatment of aggressive non-Hodgkin’s lymphoma. Review prepared June 2007. [FR, collaborating writer]

• Oncology (teaching slides for geriatrics residents). American Geriatrics Society, www.frycomm.com/ags/teachingslides, April 2007. [BAC and FR, writers]

• Caley BA. Surgeons and robots: minimally invasive technologies transform the landscape of cancer surgery. CURE: Cancer Updates, Research and Education. 2007;6(4). Also wrote sidebar: Less can be more in diagnostic imaging.

• Journal supplement about identification and treatment of oral mucositis, prepared January 2007. [FR, collaborating writer]

• Pathology and staging: how much, what it looks like and where it is guide diagnosis and treatment. CURE: Cancer Updates, Research and Education. 2007;6(1):8,11-13. [BAC, writer]

• Supplement to European Journal of Oncology Nursing, 3 articles about identification and treatment of oral mucositis, prepared January 2007. [FR, collaborating writer]

• Caley BA. Bladder cancer: breaking the research barrier. CURE: Cancer Updates, Research and Education. 2006;5(5):34-39,44-45.

• Investigator newsletters reporting on clinical trials of a therapy for oral mucositis, prepared September 2006 and March 2007. [FR, writer]

• Poster for ASCO about outcome measures for clinical trials of agents for metastatic colorectal cancer, prepared April 2006. [FR, collaborating writer]

• CME newsletter about the burden of cervical cancer, prepared September 2006. [FR, writer]

• Caley BA. In situ breast cancer: is it really cancer? CURE: Cancer Updates, Research and Education.2006;5(4):18-23,28. Also wrote sidebar: Do women under 50 need mammograms?

• Quantitative literature review on prevention of anemia, prepared May 2006. [BAC, researcher]

• Quantitative literature review on angiogenesis inhibitors, prepared May 2006. [BAC, researcher]

• The health consequences of smoking. In: Attorneys’ Textbook of Medicine. New York, NY: Matthew Bender, 2006. [BAC, substantive editor]

• Caley BA. Taking control: cancer patients deal with fear. CURE: Cancer Updates, Research and Education. 2006;5(3):64-68.

• Review about the safety of testosterone replacement therapy with regard to prostate cancer, prepared April 2006. [BAC and FR, collaborating writers]

• Caley BA. Picking up momentum for treating renal cell carcinoma. CURE: Cancer Updates, Research and Education. 2006;5(1):34-42.

• Review about the safety of using an antiangiogenic agent in metastatic colorectal cancer, prepared March 2006. [FR, collaborating writer]

• Review about the use of an antiangiogenic agent in elderly patients or patients with poor performance status, prepared January 2006. [FR, collaborating writer]

• Meeting report, national advisory board on angiogenesis inhibitors, prepared December 2005. [FR, writer]

• Report on current standards of care for prostate, pancreatic, and head and neck cancer, and carcinoid tumor, prepared November 2005. [FR, writer]

• Caley BA. The future of cancer research: recent discoveries will change the direction of treatment. CURE: Cancer Updates, Research and Education. 2005;4(4):48-55.

• Preventing death from breast cancer and prostate cancer. Prepared for Taking Care, November 2005. [BAC, writer]

• Are thyroid nodules cancerous? Prepared for Taking Care, October 2005. [BAC, writer]

• Meeting report, national advisory board on supportive care in cancer, prepared September 2005. [FR, writer]

• Review about trends in chemotherapy for lung cancer, prepared July 2005. [FR, collaborating writer]

• Caley BA. Going against the odds [living with metastatic cancer]. CURE: Cancer Updates, Research and Education. 2005;4(2):56-58,60. Also wrote two of the three sidebars to this article: Disrupting metastasis; The future of metastasis treatment.

• Meeting report, national breast cancer advisory board, prepared June 2005. [FR, writer]

• Posters for ASH, ASCO, and MASCC/ISOO annual meetings, 2005. Multiple topics regarding supportive care for cancer patients. [FR, writer]

• Quantitative literature analyses about: a hematopoietic growth factor (prepared April 2005), a novel leukemia drug (March 2005), a novel taxane (February 2005), monoclonal antibodies for breast cancer (February 2005), a novel anthracenedione (February 2005), and various antimicrobials (January 2005). [BAC, researcher]

• Caley BA. Hodgkin’s disease: the other side. CURE: Cancer Updates, Research and Education. 2005;4(1):40-47. 

• Monograph on the treatment of multiple myeloma, prepared December 2004. [BAC and FR, writers]

• Educational newsletter for sales representatives about targeted therapy, prepared Spring 2004. [FR, writer]

• Caley BA. Singling out sarcoma: why everyone should care about this uncommon disease. CURE: Cancer Updates, Research and Education. 2004;3(2):56-60, 62-63.

• Meeting report, national breast cancer advisory board, prepared June 2004. [BAC, writer]

• Quantitative literature analysis regarding chemotherapy for non-small-cell lung cancer, prepared April 2004. [BAC, researcher]

• Posters for ASCO and MASCC/ISOO annual meetings, 2004. Multiple topics regarding supportive care for cancer patients. [FR, collaborating writer]

• Herman R. Cultural diversity and cancer patient education. Poster presented at the 2004 annual meeting of the Oncology Nursing Society. [FR, collaborating writer]

• Caley BA. The future of hemophilia therapy: will it be safer and easier? HemAware. 2003;8(6):50-53.

• Caley BA and Reidenbach F. Growing older with hemophilia: a lifetime of bleeds creates problems. HemAware. 2003;8(4):59-63.

• Caley BA and Reidenbach F. Night splints: an option for treating chronic muscle tightness in people with hemophilia. HemAware. 2003;8(3):53-55.

• Walsh JME. Controversies in cancer prevention and screening. Adv Stud Med. 2003;3(6):316-325. [BAC and FR, collaborating writers]

• Caley BA and Reidenbach F. Expanding options for advanced breast cancer. CURE: Cancer Updates, Research and Education. 2003;2(3):47-53.

• National Anemia Action Council, 2002-2003. Wrote news for a physician website (http://www.anemia.org), wrote slide sets for a speakers bureau, and edited a monograph on the epidemiology, diagnosis, and treatment of anemia. Wrote news and a glossary for the launch of a consumer website and produced patient education materials. [BAC and FR]

• Reidenbach F. Conceiving solutions: Fertility and cancer treatment. CURE: Cancer Updates, Research and Education. 2002;1(4):22-26.

• Reidenbach F. Deep in the bone: Managing multiple myeloma. CURE: Cancer Updates, Research and Education. 2002;1(2):30-38.

• Reidenbach F. Novel drug delivery device may improve liver cancer outcomes. Lancet Oncol. 2002;3:450.

• Reidenbach F. Gabapentin may relieve tamoxifen-related hot flushes. Lancet Oncol. 2002;3:393.

• Reidenbach F. Researchers recommend early use of implantable drug pump. Lancet Oncol. 2002;3:386.

• Reidenbach F. Chemotherapy safe in pregnancy. Lancet Oncol. 2002;3:128.

• Boosting immunity to cancer through nutrition. Women's Health Advisor. 1998;2(1):7. [FR, writer]

Bylined news reports distributed on Reuters Health wire service [FR, writer]: 

• Telomerase immunoreactivity of prostate tumors may have diagnostic value, 12-27-2002.

• Novel apoptosis stimulators developed from COX-2 inhibitors, 12-13-2002.

• Angiogenesis inhibitor plus paclitaxel well tolerated in phase I trial, 12-5-2002.

• Novel predictor of breast cancer survival called the most powerful to date, 11-14-2002.

• CD34-selected stem cell transplantation safe for rheumatoid arthritis patients, 10-15-2002.

• Resistance to antiangiogenic agents may reflect variance in tumor biology, 10-03-2002.

• First cholinergic pathway for angiogenesis identified, 9-10-2002.

• Gleevec and other c-Kit inhibitors might treat Kaposi’s sarcoma, 8-22-2002.

• St. John’s wort alters metabolism of chemotherapeutic agent irinotecan, 8-21-2002.

• Early radiation advised for limited-stage small-cell lung cancer, 8-7-2002.

• Spiral CT promising for lung cancer screening, 8-2-2002.

• Cannabinoid receptor agonists may be novel class of anti-lymphoma agents, 7-25-2002.

• Cytokine improves immune function after bone marrow transplantation in mice, 7-5-2002.

• Public funding of Pap tests linked to lower rate of invasive cervical cancer, 7-5-2002.

• Lymphoma not common in rheumatoid arthritis patients receiving methotrexate, 6-24-2002.

• Childhood AML can begin in utero with latency as long as 12 years, 6-3-2002.

• Single clone remains dominant in paroxysmal nocturnal hemoglobinuria, 5-1-2002.

• Anthracycline/taxane neoadjuvant chemotherapy advised for breast cancer, 4-9-2002.

• Statins might fight spread of pancreatic cancer, 3-29-2002.

• Idiotype-pulsed dendritic cell vaccination can induce regression of B-cell NHL, 3-27-2002.

• Bone marrow defects seen in RA, might hinder experimental therapies, 3-22-2002.

• p53 appears to inhibit angiogenesis in non-small-cell lung cancer, 3-13-2002.

• Gene may help suppress colorectal cancer, 2-28-2002.

• Common virus linked to childhood brain tumor, 2-19-2002.

• Exposure to TNF-alpha boosts tumor angiostatin production in murine model, 2-19-2002.

• HHV-6 in cerebrospinal fluid can cause encephalitis after stem cell transplantation, 2-19-2002.

• Type of childhood leukemia linked to parental age, 2-15-2002.

• Mental difficulties can persist long after chemotherapy, 2-11-2002.

• Clues to why breast cancer more fatal in blacks, 2-7-2002.

• Postmastectomy radiation may be warranted after response to chemotherapy, 1-30-2002.

• Some lab values may predict response to hydroxyurea in sickle cell anemia, 1-29-2002.

• Capecitabine promising for advanced renal cell carcinoma, 1-23-2002.

• DNA repair ability affects risk of melanoma, 1-16-2002.

• Adult stem cells from murine skeletal muscle can become blood cells, 12-6-1999.

• Addition of cyclophosphamide could improve virus therapy for brain tumors, 7-27-1999.

• Enhanced Pap testing cost effective for infrequent screening, 1-27-1999.

• Calcium reduces risk of colorectal polyps, 1-13-1999.

• Chronic fatigue prevalent among survivors of Hodgkin’s disease, 1-13-1999.

• Gene affects immune response to cancer, 12-25-1998.

• Depression tied to cancer risk in elderly, 12-15-1998.

• Survivin seems to be an advantage factor for tumor cell expansion, 12-10-1998.

• Incident breast lesions found on MRI unlikely to be malignant, 12-2-1998.

• Proto-oncogene PML regulates immune response to tumor cells, 11-26-1998.

• Adjuvant chemo prolongs survival in high-risk node-negative breast cancer, 10-30-1998.

• Blood test may screen for ovarian cancer, 8-25-1998.

• Clinical findings predict DNA-repair gene mutations in colorectal cancer, 8-20-1998.

• Level of p27 predicts outcome in localized prostate cancer, 6-17-1998.

• Tumor suppressor gene PTEN affects cell-surface interactions, 6-8-1998.

• Modified PKC ribozyme resists nuclease without loss of efficacy, 6-1-1998.

• Blood test may detect cancer early, 4-13-1998.

• More genetic links to breast cancer, 3-31-1998.

 
• Home • Bev Caley • Faith Reidenbach • Services • What We've Written • Client Experience • What Our Clients Say •

Send mail to Bev@caleyreidenbach.com with questions or comments about this web site.
Last modified: 08/09/07